Management Team

Other Board Positions
Supervisory Board of avateramedical N.V. (2019-2021)

Notable Experience and Key Board Contributions

• At Align, Mr. Hogan has overseen significant financial and operating performance
• Mr. Hogan is a proven leader serving as an integral connection between our board of directors and management. He brings to Align significant leadership experience from large public companies, with strategic business, market development and sales acumen, and expertise in strategic and operational aspects of complex, international organizations.
• During his five years at ABB, Mr. Hogan oversaw a 25% increase in revenues.
• As CEO of GE Healthcare, Mr. Hogan drove significant geographic and market portfolio expansion and more than doubled revenues from $7 billion to $16 billion.

Education
B.S. in Business and Economics from Geneva College
M.B.A. from Robert Morris University

David Carr serves as the Executive Vice President and Managing Director, EMEA, responsible for Align Technology’s market development and operational execution of all Align Technology products and services in the EMEA region. Mr. Carr joined the company in September 2024 originally as the Executive Vice President and Managing Director, APAC. With over 25 years of management experience in healthcare and the automotive industry, Mr. Carr has established an impressive record of delivering results in the most competitive and dynamic markets across the globe. He started his career as an engineer in Japan and has spent over twenty years in med tech leadership roles with GE Healthcare and Medtronic, located in Asia, Europe, the Middle East & Africa, and the United States. Mr. Carr holds an MBA and a Bachelor of Mechanical Engineering from University College Dublin, Ireland.
 

Julie Coletti is Executive Vice President, Chief Legal and Regulatory Officer of Align Technology, where she leads Align’s world-class legal, regulatory, and quality teams and serves as corporate secretary to the Align Technology Inc.’s Board of Directors. Ms. Coletti joined the company in May 2018 as Vice President, Associate General Counsel, Strategic Commercial Affairs before her promotion to her current position in May 2019. Prior to joining Align, she served as Vice President and Global General Counsel of Danaher Corporation’s $3 billion dental medical device platform and Vice President, Chief Legal Officer at Bayer HealthCare's MEDRAD/Radiology and Interventional Division, a manufacturer of pharmaceuticals and medical devices for imaging and interventional cardiology. She began her career in litigation at LeBoeuf, Lamb, Greene & MacRae LLP before joining Bayer Corporation’s in-house litigation team.

Ms. Coletti is an experienced life sciences and technology executive, general counsel, and chief compliance officer. She has a proven track record of leading business-focused, results-oriented teams and for guiding CEOs, boards of directors and business leaders through complex litigation, regulatory, intellectual property, competition, governance, and policy issues, during periods of transformation and growth as well as more difficult times of disruption and uncertainty. She has a passion for developing individuals, recognizing hidden strengths, encouraging positive change and improvements, and fostering a culture of continuous learning that drives organizational success.

She received her J.D. from the University of Pittsburgh and her B.A. from Rutgers University. She serves as a director for Fortis Life Sciences, a trusted partner offering a portfolio of solutions to life science and diagnostic companies.

Dr. Mitra Derakhshan is currently Executive Vice President, Chief Clinical Officer,Global Treatment Planning and Clinical Services at Align Technology, responsible for the global clinical teams, including global treatment planning and clinical services. She has held numerous prior roles at Align Technology since August 2000 spanning across clinical in the areas of manufacturing, R&D, international, and global marketing. She is instrumental in many key initiatives, such as product innovation, education programs, portfolio and software development, case galleries, and research studies. Dr. Derakhshan also practices orthodontics as an associate in private practice. She has lectured worldwide on Invisalign clear aligners. Dr. Derakhshan has published in the Journal of Clinical Orthodontics, Seminars in Orthodontics, World Journal of Orthodontics; and authored many of Align Technology's continuing education materials and holds multiple patents. She is a member of the AAO, ADA, and FRCD (C). Dr. Derakhshan received her Doctor of Dental Surgery (DDS) at the University of Michigan and her Master of Science (MS) and Certificate in Orthodontics at the University of Illinois at Chicago.

JunHo Han serves as the Executive Vice President and Managing Director of the Asia Pacific region. He has responsibility for market development and operational execution of all Align Technology products and services in the APAC region. Mr. Han joined Align in January 2019 and has held senior leadership roles of increasing responsibility across China, North Asia, and the Asia Pacific region. Since joining the company, he has served as Vice President and Managing Director for China and North Asia, and has led Asia Pacific commercial operations, customer experience and sales enablement. Prior to joining Align, Mr. Han held senior leadership positions at Edwards Lifesciences and Johnson & Johnson, where he built high-performing organizations, advanced market access, and delivered strong growth across North Asia and Asia Pacific markets. Mr. Han holds an MBA from Sogang University Graduate School of Business in Korea and a Bachelor’s degree in Public Administration from Hankuk University of Foreign Studies.

Srini Kaza serves as Executive Vice President, Research & Development, responsible for leading the global product R&D group.  He joined the company in April 1999, most recently serving as Senior Vice President, Product Research & Development,  with focus areas such as Biomechanics, Advanced Materials, 3D Printing, 3D Computational Geometry, AI, Clinical Affairs, Advanced Simulation and Design, and emerging technologies and processes.

Mr. Kaza has made significant contributions over the years in developing several 3D printing technologies, scanning processes, innovative materials, 3D software and several other technologies during his tenure at Align.

Under his supervision, the R&D group has created several new products and underlying technologies that enable Invisalign product performance improvements. His team has most recently developed the Invisalign Palatal Expander product.  In addition, his team created the patented SmartTrack® material, specially engineered for the Invisalign system, and continues to work on future advancements. His team also conducts multiple clinical studies that aim to create better understanding of Invisalign product performance and manages the University Research Programs, intended to create close collaborations with universities worldwide to help advance the science in the dental field. Mr. Kaza holds an M.S. degree in Mechanical Engineering from the University of Utah and an M.B.A. degree from the Wharton School of Business.

Sreelakshmi Kolli is Executive Vice President, Chief Product and Digital Officer, responsible for our product lifecycle, from product ideation and innovation, to engineering, product launch and product performance. This includes leading the product and engineering teams and defining the technology strategy and development of product software, consumer, customer, manufacturing and enterprise applications enabling the Align Digital Platform. Ms. Kolli has led Align’s global business transformation initiative aimed at delivering platforms and technology to support customer experience and simplified business processes across the company. She joined the company in June 2003 and has held positions of increasing responsibility, leading and transforming business operations and engineering teams and platforms. Prior to joining Align, Ms. Kolli held technical lead positions with Citadon and Accenture. She is a member of the Board of Directors at Intuitive (Nasdaq: ISRG) and Zimmer Biomet Holdings, Inc. (NYSE:ZBH). Ms. Kolli earned an M.S. degree in Computer Applications at the National Institute of Technology in Trichy, India and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.

Frank Quinn serves as the Executive Vice President and Managing Director of the Americas region. He has responsibility for market development and operational execution of all Align Technology products and services in the Americas region. Mr. Quinn re-joined Align in October 2024 after spending two years at LightForce Orthodontics, where he served as Chief Revenue Officer. Prior to his role at LightForce, Mr. Quinn spent nearly 9 years at Align serving in multiple roles including Vice President and General Manager, where he was responsible for driving continued growth and profitability for the United States. During his time at Align, Mr. Quinn’s other positions included Senior Sales Director of Special Markets and iTero, Vice President of Special Markets, Business Development and Education.  Mr. Quinn has a wealth of experience driving growth, strategy and revenue in the orthodontics industry. As a successful executive leader across the medical and technology industries, he combines strong sales leadership experience with expertise in business development, innovation, professional education, commercial operations and culture building.  Mr. Quinn has also served as a Board Member of the American Association of Orthodontics Foundation (AAOF) and the American Academy of Clear Aligners (AACA).  He holds a BS in Business Administration and Marketing from Montclair State University.